Epanova® for Lowering Very High Triglycerides
Public ClinicalTrials.gov record NCT01242527. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Epanova® (Omefas) in Severe Hypertriglyceridemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to determine the efficacy of Epanova (omefas) compared to placebo in lowering serum triglycerides in subjects with severe hypertriglyceridemia.
Study identification
- NCT ID
- NCT01242527
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 399 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2011 (Type not available)
- Primary completion
- Mar 2012 (Actual)
- Completion
- Apr 2012 (Actual)
- Last update posted
- Aug 4, 2016
2011 – 2012
United States locations
- U.S. sites
- 30
- U.S. states
- 16
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | National City | California | 91950 | — |
| Not listed | Sacramento | California | 95823 | — |
| Not listed | Manchester | Connecticut | 06040 | — |
| Not listed | Coral Gables | Florida | 33134 | — |
| Not listed | Hialeah | Florida | 33012 | — |
| Not listed | Miami | Florida | 33169 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | St. Petersburg | Florida | 33709 | — |
| Not listed | Summerfield | Florida | 34461 | — |
| Not listed | Atlanta | Georgia | 30328 | — |
| Not listed | Addison | Illinois | 60101 | — |
| Not listed | Chicago | Illinois | 60654 | — |
| Not listed | Louisville | Kentucky | 40213 | — |
| Not listed | Auburn | Maine | 04210 | — |
| Not listed | Olive Branch | Mississippi | 38654 | — |
| Not listed | High Point | North Carolina | 27262 | — |
| Not listed | Salisbury | North Carolina | 28144 | — |
| Not listed | Cincinnati | Ohio | 45212 | — |
| Not listed | Cincinnati | Ohio | 45246 | — |
| Not listed | Columbus | Ohio | 43213 | — |
| Not listed | Oklahoma City | Oklahoma | 73103 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Philadelphia | Pennsylvania | 19446 | — |
| Not listed | Bristol | Tennessee | 37620 | — |
| Not listed | Johnson City | Tennessee | 37604 | — |
| Not listed | Kingsport | Tennessee | 37660 | — |
| Not listed | San Antonio | Texas | 78215 | — |
| Not listed | Norfolk | Virginia | 23502 | — |
| Not listed | Richmond | Virginia | 23294 | — |
| Not listed | Olympia | Washington | 98502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01242527, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2016 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01242527 live on ClinicalTrials.gov.